Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted)

Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) company information, Employees & Contact Information

Updated June 2026

Quick answer

Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) is a Pharmaceutical Manufacturing company. Contact data was last refreshed in June 2026. Find Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted)'s verified employee emails, phone numbers, headquarters address, and key decision makers below.

Welcome to the official account for AREXVY. Community Guidelines: https://gsk.to/422iOlQ Prescribing Information: https://gsk.to/ArexvyPI Intended for US healthcare professionals only. Trademarks are owned by or licensed to the GSK group of companies. ©2025 GSK or licensor. PMUS-RSASMP240122 February 2025 Produced in USA.

Company Details

Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Looking for a particular Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) employee's phone or email?

Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) Questions

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant